Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-350-9 | CAS number: 41395-83-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 13 Jan - 24 Jan 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Well documented GCP-study which meets basic scientific principles. No purity reported.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
- Study type:
- study with volunteers
- Endpoint addressed:
- skin irritation / corrosion
- Principles of method if other than guideline:
- Human skin irritation study after single dermal application (single patch test).
- GLP compliance:
- no
- Remarks:
- , but compliant to GCP
Test material
- Reference substance name:
- Propylene dinonanoate
- EC Number:
- 255-350-9
- EC Name:
- Propylene dinonanoate
- Cas Number:
- 41395-83-9
- Molecular formula:
- C21H40O4
- IUPAC Name:
- propylene dinonanoate
Constituent 1
Method
- Type of population:
- general
- Subjects:
- - Number of subjects exposed: 10
- Sex: female
- Age: 19-41
- Weight: 46-72 kg
- Race: Caucasian
- Social conditions: Volunteers able to justify of a fixed abode
- Intelligence quotient: Francophone volunteers, able to read the documents they were presented with and to hold to what they were explained.
- Social cover: The volunteers should be affiliated to a social security organisation.
EXCLUSION CRITERIA
- Volunteers who did not respect article L 209-17, law of 20 December 1988.
- Volunteers who participated in a test for the verification of the good cutaneous or peri-ocular local tolerance during the four last weeks and/or to active sensitisation type studies during the last six months.
- Volunteers who refused to sign the informed consent statement.
- Female volunteers, either pregnant or nursing mothers, or not using medically acceptable contraceptive methods.
- Volunteers having undergone organ excision (kidney, lung, spleen, liver), an organ transplant, a skull concussion with loss of consciousness since less than 5 years or with present after-effects.
Volunteers having:
- the following disorders: cardiovascular, pulmonar, digestive, neurologic, psychiatric, genital, haematological, endocrine, having a redhibitory aspect for the study concerned;
- an immunological deficit;
- a background of drug intolerance (local or general anaesthetics), and intolerance to cosmetics, to body hygiene or domestic products, to clothes, to products used at work such as cellophane, rubber (gloves, glues, adhesive tapes), nickel, aluminium;
- an allergic background: asthma, periodic spasmodic rhinitis;
- a skin disease, and in particular: dermographism, urticaria, edema, eczema, recurrent herpes, herpes zoster having erupted less than three months before, pityriasis versicolor, common acne with a sudden rise of inflammation or nordular or kystic acne, psoriasis, ichtyosis , lichen planus, chronic lupus erythematodis, cheloid scars, pigmentary disorders (vitiligo, chloasma, multiple lentigines, numerous or congenital nevi, especially if they are of large size), hyperhidrosis, dorsal hyperpilosity, important perspiration;
- a febrile illness: more than 24 hours of fever within the 6 days prior to the first application of the test article.
- Volunteers having had or being in the course of a long-term treatment, in particular with antihistamine, steroids, beta blocker.
- Volunteers who recently suffered from insolation, or having followed heliotherapy during the month preceding the study.
- Volunteers smoking more than 10 cigarettes a day and not accepting restriction of their tobacco consumption during two days prior to the start of the study and throughout the whole study. - Ethical approval:
- confirmed, but no further information available
- Route of exposure:
- dermal
- Reason of exposure:
- intentional
- Exposure assessment:
- not specified
- Details on exposure:
- 0.02 mL of the test substance (as supplied) were applied on the back, on a surface of about 50 mm², on a filter paper and were occlusively covered with a "Finn Chamber" (aluminium disc) and held in place with an adhesive tape. The test article was applied only once. After an exposure of 48 h, patches were removed and substantial amount of remaining test material was removed using a hydrophilic pad. Concomitantly, chambers without test substance were applied as "negative" controls.
- Examinations:
- Cutaneous macroscopic examinations was performed about 30 minutes after patch removal.
Results and discussion
- Clinical signs:
- No reaction of pathological irritation and cutaneous intolerance were noted. No subordinate effects were observed.
- Results of examinations:
- SKIN EXAMINATION
No skin reactions were observed in the study in any of the 10 volunteers.
Applicant's summary and conclusion
- Conclusions:
- The single epicutaneous application of the test substance under occlusive conditions for 48 h was well tolerated in healthy volunteers. Therefore, no indication for skin irritation was found.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.